PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

9.66USD
23 Jul 2014
Price Change (% chg)

$0.06 (+0.62%)
Prev Close
$9.60
Open
$9.66
Day's High
$9.75
Day's Low
$9.64
Volume
570,350
Avg. Vol
700,116
52-wk High
$10.20
52-wk Low
$7.39

PDLI.OQ

Chart for PDLI.OQ

About

PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies. The Company receives royalties based on sales of humanized antibody... (more)

Overall

Beta: 0.26
Market Cap (Mil.): $1,551.35
Shares Outstanding (Mil.): 160.59
Dividend: 0.15
Yield (%): 6.21

Financials

  PDLI.OQ Industry Sector
P/E (TTM): 5.43 106.71 36.40
EPS (TTM): 1.78 -- --
ROI: 75.55 0.13 18.27
ROE: 523.19 -0.64 19.15
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks